Vimarsana
Biggest News Aggregation in the World

Page 31 - Endoscopy News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Endoscopy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Endoscopy Today - Breaking & Trending Today

Boston Scientific : Four things to know about our acquisition of Apollo Endosurgery - Vimarsana News

Boston Scientific : Four things to know about our acquisition of Apollo Endosurgery

Mike Jones just celebrated his 28th year at Boston Scientific. Now a senior vice president at the company, he's also the president of the Endoscopy business - which means he knows... | April 26, 2023

Athol Daily News - Athol Hospital suspends endoscopy procedures - Vimarsana News

Athol Daily News - Athol Hospital suspends endoscopy procedures

ATHOL—Following a routine equipment assessment, Athol Hospital has suspended endoscopy procedures in the campus’ two operating rooms until further notice.According to a statement sent by Vice President of External Affairs Dawn Casavant, there have...

What's next for minimally invasive gastroenterology procedures? - Vimarsana News

What's next for minimally invasive gastroenterology procedures?

Abhishek Gulati, MD, chief of gastroenterology at Saint Agnes Medical Center in Fresno, Calif., discussed the future of minimally invasive gastroenterology procedures.

Massachusetts hospital suspends endoscopy procedures - Vimarsana News

Massachusetts hospital suspends endoscopy procedures

A Massachusetts hospital is suspending some procedures.

Taking Organoids From Bench to Bedside Through Endoscopy in Pancreatic Cancer: Expectations for the Future - Vimarsana News

Taking Organoids From Bench to Bedside Through Endoscopy in Pancreatic Cancer: Expectations for the Future

In this fifth episode of OncChats: Taking Organoids From Bench to Bedside Through Endoscopy in Pancreatic Cancer, Toufic A. Kachaamy, MD, Madappa Kundranda, MD, PhD, and Richard Burkhart, MD, provide insight into some of the regulatory challenges of organoid development and share expectations for the future of pharmacotyping in treatment selection.